fulvestrant has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (11.11) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Li, Z; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K | 1 |
| Bai, M; Chang, L; Li, G; Su, J; Tan, C; Wang, C; Wang, X; Wen, Y; Xie, L; Zhang, D | 1 |
| Chang, L; Li, GF; Su, J; Tan, CL; Wang, C; Wang, X; Wen, Y; Xie, LY; Xu, JL; Zhang, DZ; Zhang, XX | 1 |
| Bai, J; Gui, S; Zhang, Y | 1 |
| Bai, G; Cao, L; Gao, H; Gui, S; Lu, R; Wang, F; Zhang, Y | 1 |
| Cao, L; Gao, H; Gui, S; Li, P; Zhang, Y | 1 |
| Bai, J; Lan, X; Li, C; Li, Z; Liu, Q; Wu, Y; Yu, G; Zhang, Y; Zong, X | 1 |
| Guo, Y; Knosp, E; Liang, Q; Tai, G; Wang, W; Zhao, Y | 1 |
| Gui, S; Li, C; Liu, F; Sun, Z; Zhang, Y | 1 |
9 other study(ies) available for fulvestrant and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Hypophysectomy; Male; MAP Kinase Signaling System; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Receptors, Prolactin; Young Adult | 2020 |
Estrogen receptor antagonist fulvestrant inhibits proliferation and promotes apoptosis of prolactinoma cells by regulating the IRE1/XBP1 signaling pathway.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Endoplasmic Reticulum Chaperone BiP; Endoribonucleases; Estrogen Receptor Antagonists; Fulvestrant; Heat-Shock Proteins; Humans; Prolactin; Prolactinoma; Protein Precursors; Protein Serine-Threonine Kinases; Signal Transduction; X-Box Binding Protein 1 | 2018 |
Fulvestrant inhibits the glycolysis of prolactinoma GH3 cells by downregulating IRE1/XBP1 signaling pathway.
Topics: Animals; Cell Line; Down-Regulation; Endoplasmic Reticulum Chaperone BiP; Fulvestrant; Glycolysis; Heat-Shock Proteins; Prolactinoma; Protein Serine-Threonine Kinases; Rats; Signal Transduction | 2018 |
Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas.
Topics: Adult; Animals; beta Catenin; Bromocriptine; Cell Line; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Rats; Young Adult | 2013 |
Effects of the estrogen receptor antagonist fulvestrant on F344 rat prolactinoma models.
Topics: Animals; Cell Line, Transformed; Disease Models, Animal; DNA Methylation; Dose-Response Relationship, Drug; Enzyme Inhibitors; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Estrogens; Extracellular Matrix Proteins; Female; Fulvestrant; Gene Expression Regulation, Neoplastic; Indoles; Intercellular Signaling Peptides and Proteins; Maleimides; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Rats, Inbred F344; Time Factors | 2014 |
The Wnt/β-catenin signaling pathway is involved in the antitumor effect of fulvestrant on rat prolactinoma MMQ cells.
Topics: Animals; Antineoplastic Agents, Hormonal; Azacitidine; beta Catenin; Cell Line, Tumor; Cell Proliferation; Decitabine; Estradiol; Estrogen Receptor alpha; Extracellular Matrix Proteins; Fulvestrant; Intercellular Signaling Peptides and Proteins; Pituitary Neoplasms; Prolactinoma; Rats; Wnt Signaling Pathway | 2014 |
The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.
Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Male; Middle Aged; Phosphorylation; Pituitary Neoplasms; Prolactinoma; Protein Processing, Post-Translational; Rats; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Young Adult | 2015 |
Differential effects of estrogen and estrogen receptor antagonist, ICI 182 780, on the expression of calbindin-D9k in rat pituitary prolactinoma GH₃ cells.
Topics: Animals; Blotting, Western; Cell Line, Tumor; Estradiol; Estrogen Receptor Antagonists; Fluorescent Antibody Technique; Fulvestrant; Immunoprecipitation; Pituitary Neoplasms; Prolactinoma; Rats; Reverse Transcriptase Polymerase Chain Reaction; S100 Calcium Binding Protein G | 2014 |
Effects of fulvestrant, an estrogen receptor antagonist, on MMQ cells and its mechanism.
Topics: Animals; Antineoplastic Agents, Hormonal; Apoptosis; Cell Line, Tumor; Cell Proliferation; Cell Survival; Estradiol; Estrogen Antagonists; Fulvestrant; MAP Kinase Kinase 4; MAP Kinase Signaling System; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; p38 Mitogen-Activated Protein Kinases; Prolactin; Prolactinoma; Rats; Receptors, Estrogen; RNA, Messenger | 2009 |